Boston Scientific Corporation
BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardiovā¦ read more
Healthcare
Medical Devices
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$103.17
Price-0.94%
-$0.98
1Y
Price
Market Cap
$152.872b
Large
Price/Earnings 3y Avg5y Avg
61.4x
Premium
Premium
Financials Overview
Key metrics over the past few years+20.4%
EBITDA Margin+15.7%
Net Profit Margin+7.0%
Free Cash Flow MarginRevenue
$18.494b
+10.4%
1y CAGR+13.4%
3y CAGR+11.8%
5y CAGREarnings
$2.502b
+35.0%
1y CAGR+59.9%
3y CAGR+36.7%
5y CAGREPS
$1.68
+34.4%
1y CAGR+63.0%
3y CAGR+38.6%
5y CAGRBook Value
$22.445b
$40.140b
Assets$17.694b
Liabilities$11.708b
DebtDebt to Assets
29.2%
2.7x
Debt to EBITDAFree Cash Flow
$2.873b
+8.6%
1y CAGR+50.1%
3y CAGR+29.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company